INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
11/07/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of a robotic figure of a man comprised of blue tri-dimensional stylised "H" letters, with eight small miniature people walking behind, between and in front of its feet, consisting of a male in an orange sports coat with brown slacks, a female wearing a purple shirt and blue capris with a black backpack, a man in a black suit, a female in black slacks and a brown turtleneck, an elderly man with white hair, wearing a black jacket and gray pants holding a gray walking cane, a male wearing a white medical coat, and black slacks, a male wearing a blue shirt, green shorts, with a black and blue backpack and a female wearing a blue top and blue pants.
Titulares
Representantes
Amanda Nye Amanda Nye Law Offices
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations, namely, anti-inflammatory drugs, antiemetic drugs, drugs for the treatment of cancer, carcinoma, leukemia, lymphoma, melanoma, anti-tumor drugs, anti-emetic, anti-tumor and anticancer pharmaceutical preparations for the treatment of oncological diseases and the side effects of treatment; drugs for use in case of ulcerative and inflammatory conditions, anti-anxiety drugs, anti-migraine drugs, cognition enhancing drugs, drugs for the prevention and treatment of gastroenterological, hepatologic, nephrologic and cardiovascular disorders of any origin; drugs for internal cleansing purposes, bowel cleansers and evacuants for medical and pharmaceutical purposes, veterinary vaccines and sanitary preparations for medical use; dietetic foods adapted for medical use, food for babies; medical and surgical plasters, materials for dressings in the nature of bandages; material for stopping teeth, dental wax; disinfectants for sanitary and hygiene purposes; preparations for destroying vermin; fungicides, herbicides
Classe 40
Treatment and transformation of chemical, biochemical and pharmaceutical products during the manufacture of pharmaceutical products for others
Classe 42
Research and development of pharmaceutical products; scientific and industrial research for the development of medicines and active ingredients; consultancy in the field of chemical and pharmaceutical technology; engineering services, including expertise in the field of chemical and pharmaceutical technology
Classe 45
Reviewing standards and practices to assure compliance with pharmaceutical laws and regulations, regulatory compliance consulting to ensure compliance with public sector procurement and regulations in the field of chemical, biochemical pharmaceuticals and procurement in the field of chemical, biochemical pharmaceuticals and legal consultancy, in particular before and during national proceedings in the field of regulation of chemical, biochemical and pharmaceutical products licensing of intellectual property in the field of chemical, biochemical and pharmaceutical technologies and Licensing in the field of chemical, biochemical and pharmaceutical products; exploitation of intellectual property rights, particularly licensing of intellectual property including know-how in the field of chemical, biochemical and pharmaceutical technologies
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
11/07/2026
INVALIDATION PROCESSED
11/07/2026
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
18/12/2025
NEW REPRESENTATIVE AT IB RECEIVED
20/11/2025
CANCELLED SECTION 71
18/04/2025
NEW REPRESENTATIVE AT IB RECEIVED
19/07/2024
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/10/2023
FINAL DECISION TRANSACTION PROCESSED BY IB
01/02/2019
FINAL DISPOSITION NOTICE SENT TO IB
15/01/2019
FINAL DISPOSITION PROCESSED
15/01/2019
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/01/2019
REGISTERED-PRINCIPAL REGISTER
02/10/2018
NOTIFICATION PROCESSED BY IB
24/07/2018
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/07/2018
PUBLISHED FOR OPPOSITION
17/07/2018
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/07/2018
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/07/2018
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/06/2018
WITHDRAWN FROM PUB - OG REVIEW QUERY
05/06/2018
APPROVED FOR PUB - PRINCIPAL REGISTER
21/05/2018
TEAS/EMAIL CORRESPONDENCE ENTERED
18/04/2018
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/04/2018
ASSIGNED TO LIE
12/04/2018
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/03/2018
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/03/2018
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/03/2018
REFUSAL PROCESSED BY IB
04/11/2017
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
17/10/2017
REFUSAL PROCESSED BY MPU
17/10/2017
APPLICATION FILING RECEIPT MAILED
17/10/2017
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/10/2017
NON-FINAL ACTION WRITTEN
14/10/2017
ASSIGNED TO EXAMINER
12/10/2017
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/10/2017
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/10/2017
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.